Health Canada Authorizes Moderna Mrna Flu And Combination Vaccines

New Vaccine Authorizations

Two new mRNA-based vaccines from Moderna have received authorization from Health Canada. One of these is a dedicated vaccine for influenza, while the other is a combination product that targets both the flu and COVID-19. Currently, these authorizations are limited to adults who are 50 years of age or older. This move makes Canada the first country to authorize both of these specific mRNA-based options.

Distribution And Timing

Despite the recent approval, these vaccines will not be available in pharmacies in time for the current respiratory virus season. While the authorization is a significant step, the timing means that the public cannot access these specific mRNA options for the immediate upcoming wave of seasonal illnesses.

Current Immunization Recommendations

The National Advisory Committee on Immunization continues to suggest that individuals aged six months and older receive the standard non-mRNA flu shots available this year. For those aged 65 and older, a higher-dose version of the influenza vaccine is recommended to provide a stronger immune response, as aging systems often require more stimulation.

Additionally, there is a strong recommendation for COVID-19 vaccinations for people 65 and older, as well as for those living in assisted living facilities, retirement homes, or long-term care centers. Currently, mRNA COVID-19 vaccines from both Pfizer and Moderna remain available within the country for the current year.